| P2093 | author name string | Yukio Ando | |
| | Kenichi Ishibashi | |
| | Eiji Kusano | |
| | Yoshiyuki Morishita | |
| | Shigeaki Muto | |
| | Akihiko Numata | |
| | Fumi Takemoto | |
| | Mari Okada | |
| | Atushi Miki | |
| P2860 | cites work | Metabolic acidosis and progression of chronic kidney disease: incidence, pathogenesis, and therapeutic options | Q26999274 |
| | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 |
| | Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study | Q31126016 |
| | Nephrology: 3. Safe drug prescribing for patients with renal insufficiency | Q34011083 |
| | Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients | Q34927028 |
| | Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease | Q35687482 |
| | Drug dosing in chronic kidney disease | Q36065339 |
| | Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives. | Q37769852 |
| | Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia. | Q37989772 |
| | Effect of blood pressure on early decline in kidney function among hypertensive men. | Q39566197 |
| | Minor renal dysfunction: an emerging independent cardiovascular risk factor | Q43014435 |
| | The prevalence of anemia in patients with chronic kidney disease | Q45070902 |
| | Performance of cancer screening in a university general internal medicine practice: comparison with the 1980 American Cancer Society Guidelines | Q46099653 |
| | Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q46480414 |
| | Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis | Q46610834 |
| | Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease | Q46703308 |
| | Cross-Sectional Analysis of Abnormalities of Mineral Homeostasis, Vitamin D and Parathyroid Hormone in a Cohort of Pre-Dialysis Patients | Q57496373 |
| | Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease | Q79337877 |
| | K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease | Q80010742 |
| | Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients | Q80333828 |
| | Evidence-based practice guideline for the treatment of CKD | Q84978295 |
| P433 | issue | 5 | |
| P304 | page(s) | 690-696 | |
| P577 | publication date | 2013-11-02 | |
| P1433 | published in | Clinical and experimental nephrology | Q26842022 |
| P1476 | title | Medication-prescribing patterns of primary care physicians in chronic kidney disease | |
| P478 | volume | 18 | |